Status:
COMPLETED
INSIGHTS ICD Registry
Lead Sponsor:
Medtronic Cardiac Rhythm and Heart Failure
Collaborating Sponsors:
Medtronic
Conditions:
Ventricular Tachycardia
Ventricular Fibrillation
Eligibility:
All Genders
18+ years
Brief Summary
The purpose of the Registry is to collect data on how Implantable Cardioverter Defibrillator (ICD) therapies and medications are being used by physicians to treat ventricular arrhythmias in order to b...
Eligibility Criteria
Inclusion
- Patients 18 years of age or older.
- Patients or legal guardians who are willing and able to sign a Permission for Access to and Use of Health Information in a Registry Form and, if required by an Institution's IRB, an Informed Consent.
- New or replacement implants of Medtronic market released single, dual or triple chamber ICDs including: GEM VR, GEM DR, GEM III AT, Marquis VR, Marquis DR, Maximo DR, Maximo VR, InSync ICD, InSync Marquis ICD and InSync II Marquis ICD.
Exclusion
- Patients enrolled in a device study which effects programming and or treatment.
Key Trial Info
Start Date :
February 1 2004
Trial Type :
OBSERVATIONAL
End Date :
January 1 2006
Estimated Enrollment :
1326 Patients enrolled
Trial Details
Trial ID
NCT00279968
Start Date
February 1 2004
End Date
January 1 2006
Last Update
December 28 2007
Active Locations (44)
Enter a location and click search to find clinical trials sorted by distance.
1
Little Rock, Arkansas, United States
2
Fountain Valley, California, United States
3
Poway, California, United States
4
Sacramento, California, United States